These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36032659)
41. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L; Xie R; Lu G Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555 [TBL] [Abstract][Full Text] [Related]
42. Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer. Huang L; Lin H; Kang L; Huang P; Huang J; Cai J; Xian Z; Zhu P; Huang M; Wang L; Xian CJ; Wang J; Dong J J Cell Physiol; 2019 May; 234(5):7032-7039. PubMed ID: 30317592 [TBL] [Abstract][Full Text] [Related]
43. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
44. Integrated Analysis of a Ferroptosis-Related LncRNA Signature for Evaluating the Prognosis of Patients with Colorectal Cancer. Xu S; Zhou Y; Luo J; Chen S; Xie J; Liu H; Wang Y; Li Z Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741856 [TBL] [Abstract][Full Text] [Related]
45. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
46. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
47. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer. Tang R; Chen J; Tang M; Liao Z; Zhou L; Jiang J; Hu Y; Liao Q; Xiong W; Tang Y; Nie S Int J Biol Sci; 2019; 15(13):2885-2896. PubMed ID: 31853225 [TBL] [Abstract][Full Text] [Related]
48. Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1. Huang FK; Zheng CY; Huang LK; Lin CQ; Zhou JF; Wang JX J Gene Med; 2021 Jan; 23(1):e3285. PubMed ID: 33037865 [TBL] [Abstract][Full Text] [Related]
49. Long Non-Coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) Plays a Critical Role in Predicting Clinical Prognosis and Progression of Colorectal Cancer. Zhang XT; Pan SX; Wang AH; Kong QY; Jiang KT; Yu ZB Med Sci Monit; 2019 Aug; 25():6429-6435. PubMed ID: 31452526 [TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA SH3PXD2A-AS1 promotes colorectal cancer progression by regulating p53-mediated gene transcription. Hou P; Lin T; Meng S; Shi M; Chen F; Jiang T; Li Z; Li M; Chu S; Zheng J; Bai J Int J Biol Sci; 2021; 17(8):1979-1994. PubMed ID: 34131400 [TBL] [Abstract][Full Text] [Related]
51. Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer. Tang Q; Hu X; Guo Q; Shi Y; Liu L; Ying G Front Genet; 2022; 13():704988. PubMed ID: 35664303 [No Abstract] [Full Text] [Related]
52. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer. Wang XC; Liu Y; Long FW; Liu LR; Fan CW Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362 [TBL] [Abstract][Full Text] [Related]
53. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955 [TBL] [Abstract][Full Text] [Related]
54. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer. Zheng J; Guo J; Cao B; Zhou Y; Tong J Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292 [TBL] [Abstract][Full Text] [Related]
55. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer. Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178 [TBL] [Abstract][Full Text] [Related]
56. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059 [TBL] [Abstract][Full Text] [Related]
57. m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients. Xu C; He T; Shao X; Gao L; Cao L Front Oncol; 2022; 12():920023. PubMed ID: 36119534 [TBL] [Abstract][Full Text] [Related]
58. High-expression of LncRNA MAFG-AS1 is associated with the prognostic of patients with colorectal cancer. Cui W; Wang Y; Shen X; Wu X; Liu H; Xu X Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1530-1535. PubMed ID: 33295405 [TBL] [Abstract][Full Text] [Related]
59. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010 [TBL] [Abstract][Full Text] [Related]
60. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]